References
Organization WHO (2012) WHO global report: mortality attributable to tobacco. Geneva, World Health, p 392. http://whqlibdoc.Who.Int/publications/2012/9789241564434_eng.Pdf
Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, Caruso M, Russo C, Polosa R (2016) Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med 11:85–94
Messner B, Bernhard D (2014) Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34:509–515
Ma J, Wang X, Gao M, Ding Y, Guan Y (2016) Effect of smoking status on coronary artery disease among Chinese post-menopausal women. Intern Emerg Med 11:529–535
Pini A, Boccalini G, Baccari MC et al (2016) Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin). J Cell Mol Med 20:891–902
Becatti M, Marcucci R, Bruschi G, Taddei N, Bani D, Gori AM, Giusti B, Gensini GF, Abbate R, Fiorillo C (2014) Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arterioscler Thromb Vasc Biol 34:1355–1361
Barygina VV, Becatti M, Soldi G, Prignano F, Lotti T, Nassi P, Wright D, Taddei N, Fiorillo C (2013) Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep 18:100–106
Becatti M, Fiorillo C, Gori AM, Marcucci R, Paniccia R, Giusti B, Violi F, Pignatelli P, Gensini GF, Abbate R (2013) Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. Atherosclerosis 231:392–400
Pastori D, Carnevale R, Pignatelli P (2014) Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases? Intern Emerg Med 9:123–131
Fiorillo C, Becatti M, Attanasio M, Lucarini L, Nassi N, Evangelisti L, Porciani MC, Nassi P, Gensini GF, Abbate R, Pepe G (2010) Evidence for oxidative stress in plasma of patients with Marfan syndrome. Int J Cardiol 145:544–546
Angelico F, Loffredo L, Pignatelli P, Augelletti T, Carnevale R, Pacella A, Albanese F, Mancini I, Di Santo S, Del Ben M, Violi F (2012) Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome. Intern Emerg Med 7:219–227
Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478
Undas A, Szułdrzynski K, Stepien E, Zalewski J, Godlewski J, Tracz W, Pasowicz M, Zmudka K (2008) Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 196:551–557
Becatti M, Emmi G, Silvestri E, Bruschi G, Ciucciarelli L, Squatrito D, Vaglio A, Taddei N, Abbate R, Emmi L, Goldoni M, Fiorillo C, Prisco D (2016) Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behçet disease. Circulation 133:302–311
Rahman MM, Laher I (2007) Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 5:276–292
Toda N, Toda H (2010) Nitric oxide-mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol 649:1–13
Becatti M, Boccalini G, Pini A, Fiorillo C, Bencini A, Bani D, Nistri S (2015) Protection of coronary endothelial cells from cigarette smoke-induced oxidative stress by a new Mn(II)-containing polyamine-polycarboxilate scavenger of superoxide anion. Vascul Pharmacol 75:19–28
Finkel T (2005) Radical medicine: treating ageing to cure disease. Nat Rev Mol Cell Biol 6:971–976
Lemaître V, Dabo AJ, D’Armiento J (2011) Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci 123:542–549
Lavi S, Prasad A, Yang EH et al (2007) Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 115:2621–2627
Rudolph TK, Rudolph V, Baldus S (2008) Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc Am Thorac Soc 5:820–823
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20:1126–1167
Davì G, Santilli F (2012) Platelets, oxidative stress and preservation of the vascular endothelium: is it a matter of fat? Intern Emerg Med 7:199–201
Emmi G, Silvestri E, Squatrito D et al (2015) Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J 13:15
Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52:601–623
Ho PP, Lee LY, Zhao X, Tomooka BH, Paniagua RT, Sharpe O, BenBarak MJ, Chandra PE, Hueber W, Steinman L, Robinson WH (2010) Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol 184:379–390
Miniati M, Fiorillo C, Becatti M et al (2010) Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med 181:992–996
Barua RS, Sy F, Srikanth S et al (2010) Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol 30:75–79
Ariens RA, Kohler HP, Mansfield MW et al (1999) Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 19:2012–2016
Rinder HM, Schuster JE, Rinder CS et al (1998) Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 91:1288–1294
Yin W, Rubenstein DA (2013) Differences between mainstream and sidestream tobacco smoke extracts and nicotine in the activation and aggregation of platelets subjected to cardiovascular conditions in diabetes. Diab Vasc Dis Res 10:57–64
Fusegawa Y, Goto S, Handa S et al (1999) Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 93:271–278
Loffredo L, Carnevale R, Perri L, Catasca E, Augelletti T et al (2011) NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate. Heart 97:1776–1781
Santos-Garcia D, Blanco M, Serena J, Rodriguez-Yanez M, Leira R et al (2011) Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovasc Dis 32:155–162
Orem A, Yucesan FB, Orem C, Akcan B, Kural BV et al (2013) Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects. J Clin Lipidol 7:123–131
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The Authors declare that they have no conflict of interest.
Statements on human and animal rights
This article does not contains any study with human participants or animals.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Becatti, M., Fiorillo, C. Hazelnut-enriched chocolate improves flow-mediated artery dilatation via inhibition of oxidative stress. Intern Emerg Med 13, 1175–1177 (2018). https://doi.org/10.1007/s11739-018-1945-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-1945-4